Convergence of pathology in dementia with Lewy bodies and Alzheimer’s disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease-Reference-Cited by-同舟云学术

Convergence of pathology in dementia with Lewy bodies and Alzheimer’s disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease

Published:2014-05-24 Issue:7 Volume:137 Page:1958-1970
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Winslow Ashley R.,Moussaud Simon,Zhu Liya,Post Katherine L.,Dickson Dennis W.,Berezovska Oksana,McLean Pamela J.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Reference50 articles.

1. Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging;Berezovska;J Neurosci,2003

2. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein;Berezovska;J Neurosci,2005

3. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy;Bodner;J Mol Biol,2009

4. Familial dementia with Lewy bodies with an atypical clinical presentation;Bonner;J Geriatr Psychiatry Neurol,2003

5. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology;Brett;Arch Neurol,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer’s Disease and Other Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-02-01

2. Live FRET-FLIM Imaging to Study Metabotropic Signaling via the NMDA Receptor;Neuromethods;2024

3. FRET-based assays for neurological disease and diagnostics;Smart Diagnostics for Neurodegenerative Disorders;2024

4. Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease;Antibodies;2023-06-19

5. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease;International Journal of Molecular Sciences;2023-05-08